Stay updated with breaking news from Binding Site. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Thermo Fisher Scientific’s acquisition of The Binding Site brings a company that specializes in diagnostic tests for blood cancers and immune system disorders. It’s Thermo Fisher’s biggest acquisition since its 2021 buyout of contract research organization PPD.
/PRNewswire/ -- Nordic Capital and Five Arrows have entered into a definitive agreement to sell The Binding Site, a global leader in specialty diagnostics, to...
(2022-10-31 | NYSE:TMO) Thermo Fisher Scientific Continues to Execute Proven Capital Deployment Strategy
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has entered into a definitive agreement to acquire The Binding Site Group (“The Binding Site”), a global leader in specialty diagnostics, from a shareholder group led by European private equity ...
The company is acquiring The Binding Site Group from private equity firm Nordic Capital.